A carregar...
Dasatinib promotes TRAIL‐mediated apoptosis by upregulating CHOP‐dependent death receptor 5 in gastric cancer
Dasatinib, a tyrosine kinase inhibitor, has been approved for first‐line treatment of leukemia and has also been evaluated for use in numerous other cancers. However, its role in gastric cancer (GC) remains unclear. Therefore, the aim of this study was to investigate how dasatinib suppresses the gro...
Na minha lista:
| Publicado no: | FEBS Open Bio |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5929929/ https://ncbi.nlm.nih.gov/pubmed/29744288 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/2211-5463.12404 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|